Manufacturer of drug delivery devices. Products include inhalers and nebulizers for asthma and other respiratory pharmaceuticals, and drug delivery devices for dermatology pharmaceuticals and wound treatment. Also a provider of drug delivery device R&D services. Products and services are sold to the pharmaceutical industry. The bulk of revenue is derived from activity in the medical industry. This company was capitalized by corporate investment, private investment and venture capital. Stock symbol: IYXI. International sales are over 25% of sales. Products include drug delivery R&D services, drug delivery devices, wound healing/treatment devices, nebulizers.